Astrana Health, Inc.
ASTH
$29.19
-$0.64-2.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -39.99% | -62.84% | -63.86% | -65.45% | -48.94% |
| Total Other Revenue | 53.26% | 57.53% | 49.89% | 32.89% | 25.22% |
| Total Revenue | 51.97% | 54.81% | 46.72% | 29.71% | 22.76% |
| Cost of Revenue | 61.02% | 63.42% | 50.48% | 31.66% | 23.83% |
| Gross Profit | 5.43% | 11.49% | 26.25% | 19.73% | 17.55% |
| SG&A Expenses | 21.56% | 21.32% | 36.87% | 51.80% | 55.96% |
| Depreciation & Amortization | 34.03% | 59.99% | 57.36% | 46.10% | 25.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.88% | 59.35% | 49.39% | 33.49% | 26.32% |
| Operating Income | -25.09% | -12.10% | 5.60% | -16.13% | -14.86% |
| Income Before Tax | -45.86% | -29.67% | -10.04% | -15.83% | -7.58% |
| Income Tax Expenses | -16.04% | -15.78% | -3.45% | -38.50% | -43.12% |
| Earnings from Continuing Operations | -58.50% | -36.85% | -13.69% | 0.97% | 25.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -231.37% | -2,275.13% | -336.51% | 138.96% | 125.11% |
| Net Income | -63.08% | -43.92% | -28.93% | 39.93% | 49.52% |
| EBIT | -25.09% | -12.10% | 5.60% | -16.13% | -14.86% |
| EBITDA | -14.12% | -0.05% | 14.57% | -7.21% | -9.48% |
| EPS Basic | -64.34% | -45.29% | -30.42% | 37.84% | 45.74% |
| Normalized Basic EPS | -49.38% | -33.75% | -30.59% | -6.80% | -15.52% |
| EPS Diluted | -64.67% | -45.52% | -30.91% | 37.52% | 47.66% |
| Normalized Diluted EPS | -49.47% | -33.92% | -30.79% | -6.86% | -14.81% |
| Average Basic Shares Outstanding | 1.45% | 1.22% | 0.96% | 3.92% | 4.21% |
| Average Diluted Shares Outstanding | 1.45% | 1.31% | 1.10% | 4.04% | 3.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.73% | -0.84% | -1.00% | 10.83% | 1.96% |